Shenzhen Rui Medical ( Deep Core)

In 2017, Qiao Xin and Yiming Li founded Shenzhen Rui Medical, also known as Deepwise, with a vision to revolutionize the medical imaging industry through artificial intelligence. The company focused on developing AI-based solutions for clinical imaging, aiming to enhance early-stage cancer detection and improve diagnostic accuracy.

Deepwise quickly gained recognition for its innovative approach, leveraging cutting-edge AI technology to provide clinical imaging services that assist healthcare professionals in making more informed decisions. Their platform offered automated image analysis and reporting solutions, which streamlined workflows and increased efficiency in medical settings.

In a significant milestone, Deepwise secured a Series D funding round, which propelled the company into a new phase of growth. This influx of capital enabled them to expand their research and development efforts, further refining their AI algorithms and broadening their product offerings.

As Deepwise continued to grow, they remained committed to their mission of transforming healthcare through technology. Their solutions not only improved patient outcomes but also reduced the burden on medical professionals, allowing for more personalized and timely care.

Today, Deepwise stands as a leader in the field of AI-driven medical imaging, with a strong presence in both domestic and international markets. Their journey reflects the power of innovation and the impact of technology in advancing the healthcare industry.